Best Telehealth Clinics in Kentucky (2026)

Kentucky's telehealth statutes are codified at KRS 211.332 through 211.338 (definitions and framework) and KRS 304.17A-138 (insurance coverage). The law permits controlled substance prescribing via telehealth under a "good faith prior examination" standard, which can be satisfied through a telehealth encounter. No mandatory in-person visit is required before prescribing most controlled substances, including testosterone.

Kentucky prohibits establishing a physician-patient relationship for prescribing based solely on an internet questionnaire or telephone call. A live clinical interaction — either video or in-person — is required. This is consistent with most states and reflects the federal standard.

Payment parity is required for plans issued or renewed after January 1, 2022. Insurers must reimburse telehealth services at the same rate as in-person services. Kentucky Medicaid does not require telehealth providers to maintain a Kentucky physical address if they exclusively offer telehealth, which supports out-of-state provider access.

Kentucky is an active IMLC member, enabling expedited licensure for out-of-state physicians. Combined with the absence of an in-person requirement for controlled substances, Kentucky is moderately accessible for telehealth prescribing.

Kentucky has reduced NP practice authority. APRNs must operate under a collaborative agreement with a physician (CAPA-CS for controlled substances, CAPA-NS for non-scheduled). NPs with four or more years of experience can petition to dissolve the CAPA-CS requirement under SB 94 (2023), but full practice authority has not been achieved statewide. This affects NP-staffed telehealth platforms.

The Kentucky PDMP (KASPER) is mandatory. Providers must check KASPER before prescribing Schedule II through V controlled substances. Optometrists are specifically prohibited from prescribing controlled substances via telehealth — a unique Kentucky restriction that does not affect TRT or GLP-1 prescribing by physicians or NPs.

Kentucky has 4.5 million residents. Provider availability is good, supported by IMLC membership and no in-person requirement for controlled substances. Most national telehealth platforms serve the state.

All major TRT providers serve Kentucky. Maximus ($100/mo, all 50 states), Hone Health ($25/mo, all 50 states), TRT Nation ($99/mo, 45 states including KY), BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available. Enhance MD also serves Kentucky.

GLP-1 availability is unrestricted. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, MEDVi, Shed, Sunlight, and Mochi Health all serve Kentucky. Kentucky Medicaid does not cover GLP-1s for obesity, so patients pay out of pocket or through commercial insurance.

All HRT, hair loss, and ED providers with national coverage serve Kentucky. Midi Health accepts insurance. No known state-specific provider exclusions for KY.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year), Defy Medical $200/mo ($2,800/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Kentucky Medicaid does not cover GLP-1 receptor agonists for obesity. Patients seeking weight management medication must pay out of pocket or use commercial insurance with obesity drug coverage.

Kentucky does not tax prescription medications. The state sales tax is 6% but Rx drugs are exempt. Kentucky has a flat income tax of 3.5% (reduced from 4% effective January 1, 2026).

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

TRT (testosterone replacement therapy)

Kentucky does not require an in-person visit for TRT prescribing via telehealth. The "good faith prior examination" under KRS 211.332 can be satisfied through a video telehealth encounter. KASPER PDMP check required. Both compounded and FDA-approved testosterone are available. APRN collaborative practice requirements may limit NP-staffed platforms.

GLP-1 weight loss

No state-specific GLP-1 restrictions in Kentucky. Federal FDA compounding rules apply. Kentucky Medicaid does not cover GLP-1s for obesity. Commercial insurance coverage varies by plan.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Kentucky. No additional state restrictions apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Kentucky. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Kentucky. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Kentucky. Non-controlled peptides have fewer prescribing barriers. KASPER check required for any controlled peptide prescriptions.